We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+23.21%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$27.1B
AUM Growth
+$4.43B
Cap. Flow
-$86.6M
Cap. Flow %
-0.32%
Top 10 Hldgs %
21.67%
Holding
2,442
New
109
Increased
1,083
Reduced
1,137
Closed
107

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$40M
2
AGN
Allergan plc
AGN
+$32.5M
3
RTN
Raytheon Company
RTN
+$26M
4
PSA icon
Public Storage
PSA
+$21M
5
ALL icon
Allstate
ALL
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 24.66%
2 Healthcare 14.4%
3 Financials 13.15%
4 Consumer Discretionary 10.5%
5 Communication Services 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCF
2101
DELISTED
Chase Corporation
CCF
$248K ﹤0.01%
+2,424
New +$226K
SNEX icon
2102
StoneX
SNEX
$9.39B
$247K ﹤0.01%
22,766
-6,672
-23% -$57.9K
DNLI icon
2103
Denali Therapeutics
DNLI
$3.86B
$245K ﹤0.01%
+10,153
New +$239K
RNST icon
2104
Renasant Corp
RNST
$3.96B
$245K ﹤0.01%
9,829
-4,768
-33% -$113K
TWST icon
2105
Twist Bioscience
TWST
$5.69B
$245K ﹤0.01%
+5,416
New +$194K
AVYA
2106
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$245K ﹤0.01%
19,788
+4,898
+33% +$56.4K
HURN icon
2107
Huron Consulting
HURN
$2.61B
$244K ﹤0.01%
5,508
+664
+14% +$29.9K
KPTI icon
2108
Karyopharm Therapeutics
KPTI
$159M
$244K ﹤0.01%
858
-48
-5% -$14.2K
MFIC icon
2109
MidCap Financial Investment
MFIC
$796M
$244K ﹤0.01%
25,490
-21,264
-45% -$192K
OSG
2110
Octave Specialty Group
OSG
$250M
$243K ﹤0.01%
16,990
-7,626
-31% -$111K
ATRA icon
2111
Atara Biotherapeutics
ATRA
$73.6M
$243K ﹤0.01%
668
-12
-2% -$3.03K
UVE icon
2112
Universal Insurance Holdings
UVE
$1.23B
$243K ﹤0.01%
13,716
-1,879
-12% -$33.2K
NVMI
2113
Nova
NVMI
$12.5B
$242K ﹤0.01%
+5,028
New +$214K
PRSU
2114
Pursuit Attractions and Hospitality Inc
PRSU
$1.4B
$241K ﹤0.01%
+12,660
New +$256K
BECN
2115
DELISTED
Beacon Roofing Supply, Inc.
BECN
$241K ﹤0.01%
+9,153
New +$205K
RDWR icon
2116
Radware
RDWR
$1.05B
$240K ﹤0.01%
+10,164
New +$233K
TEN
2117
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$240K ﹤0.01%
31,680
-33,192
-51% -$194K
AGX icon
2118
Argan
AGX
$8.13B
$239K ﹤0.01%
5,038
-1,295
-20% -$49.5K
KBAL
2119
DELISTED
Kimball International
KBAL
$239K ﹤0.01%
20,705
+1,058
+5% +$12.1K
MGP
2120
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$239K ﹤0.01%
8,797
-432
-5% -$11.1K
PS
2121
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$239K ﹤0.01%
+13,234
New +$224K
DCOM
2122
DELISTED
Dime Community Bancshares
DCOM
$239K ﹤0.01%
17,440
-14,052
-45% -$203K
LX
2123
LexinFintech Holdings
LX
$246M
$238K ﹤0.01%
22,389
+10,595
+90% +$94.4K
AVD icon
2124
American Vanguard Corp
AVD
$70.4M
$237K ﹤0.01%
17,191
-606
-3% -$8.13K
CTBI icon
2125
Community Trust Bancorp
CTBI
$1.42B
$237K ﹤0.01%
+7,246
New +$233K

Similar funds

Aperio Group's Q2 2020 Portfolio in Review

As of Q2 2020, Aperio Group held 2,442 positions worth $27.1B, up 20% from $22.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q2 2020 filing shows 109 new, 1,083 increased, 1,137 reduced and 107 closed positions. Its largest new stake was Arconic Corporation: 1,326,595 shares worth $18.5M. The largest sale was AT&T, an estimated $40M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Aperio Group's largest Q2 2020 buy was Arconic Corporation: 1,326,595 shares worth $18.5M.
  • Aperio Group added most to Amazon in Q2 2020, an estimated $35.6M increase.
  • Aperio Group's biggest Q2 2020 reduction was AT&T, cutting an estimated $40M.
  • Aperio Group fully exited Allergan plc in Q2 2020, selling an estimated $32.5M.
  • Aperio Group's ten largest holdings make up 22% of its $27.1B portfolio in Q2 2020.
  • Aperio Group opened 109 new positions and closed 107 in Q2 2020.
  • Aperio Group's portfolio value rose 20% quarter-over-quarter to $27.1B.

Based on Aperio Group's 13F filing for Q2 2020, filed 13 Aug 2020.